Steady as she goes. Grabbing ground early in the week and holding it through the end. This isn't likely to be a sell in May and go away stock this year.

The masterminds in the C-suite continue to strut their stuff by amending protocol to meet deadlines. I expect they'll do the same with B-OM as necessary when it comes time for deal making. I'm betting the three they've already treated are 3/3 100% remission with video scope evidence so they are plenty comfortable with only two more. We'll know shortly though.

I would have loved more shares at last weeks prices...a guy's Dairy Queen check only goes so far at these prices...